Distinguished Speakers in Oncology Series

Bladder Cancer is a heterogeneous disease with the majority of patients presenting with non-muscle invasive and 25% with muscle invasive disease.

Luke Gilbert, Ph.D. - Associate Professor, University of California, San Francisco, Core Investigator, Arc Institute, University of California, San Francisco School of Medicine

Xianghong Jasmine Zhou, Ph.D. - Professor, Department of Pathology and Lab Medicine, University of California, Los Angeles

Dawn Hershman - Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, Chief, Division of Hematology/Oncology, Deputy Director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

Yibin Kang, Ph.D. - Warner-Lambert/Parke-Davis Professor of Molecular Biology, American Cancer Society Research Professor, Ludwig Institute for Cancer Research-Princeton, Department of Molecular Biology, Princeton University